|
|
||||
![]() |
Friday Aug 08
|
|||
| |
||||
Merrill Lynch: Revenue Flops, Income Drops, Stock Popsby Motley Fool - April 22, 2008 - 0 comments
By Morgan Housel: With shares cut nearly in half during the past year, anything short of the apocalypse was bound to come as good news for Merrill Lynch (NYSE: MER). " title="Merrill Lynch: Revenue Flops, Income Drops, Stock Pops"/>By Morgan Housel: With shares cut nearly in half during the past year, anything short of the apocalypse was bound to come as good news for Merrill Lynch (NYSE: MER). Brace yourself During the quarter, Merrill wrote down more than $6 billion, pushing the total amount it has had to ax off its books to around $30 billion since the credit crunch began to unfold last summer. Nonetheless, Merrill claims to have $82 billion in excess liquidity and remains bent on weathering the storm. Like many of its Wall Street neighbors, Merrill plans on cutting jobs to adjust to the sluggish market. Around 4,000 employees are expected to receive pink slips. Most of the cuts will come from Merrill's investment banking, global markets, and support divisions, and likely won't have much of an impact on its prominent broker division. The cuts are expected to bring a $350 million restructuring charge next quarter, but spur $800 million per year in savings after that. CEO John Thain, a former Goldman Sachs (NYSE: GS) and NYSE Euronext (NYSE: NYX) executive, hinted that brighter days likely won't arrive for at least a few quarters. Rivals Morgan Stanley (NYSE: MS) and Citigroup (NYSE: C), among others, have chopped off billions in assets from their books and raised massive amounts of cash to shore up shattered balance sheets. Merrill itself has loaded up with $12 billion in fresh capital since last fall. Thain said earlier this month that Merrill's war chest was hefty enough that the company doesn't need to raise more cash -- which can dilute existing shareholders' stakes. But he altered that a bit on Thursday, hinting at the possibility of issuing preferred shares in a similar manner to JPMorgan 's (NYSE: JPM) recent $6 billion injection. Buckle up |
|
||||||
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision. ©2004-2008 All Rights Reserved unless mentioned otherwise. [Submit News/Press Release][Terms of Service] [Privacy Policy] [About us] [Contact us] |